Diagnostic concordance of histologic lung cancer type between bronchial biopsy and cytology specimens taken during the same bronchoscopic procedure

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 10, 2010, Pages 1504-1512

  Sackett, Melanie K ^a   Salomão, Diva R ^a   Donovan, Janis L ^a   Yi, Eunhee S ^a   Aubry, Marie Christine ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BIOPSY; BRONCHOSCOPY; BRONCHUS; CASE REPORT; CLASSIFICATION; CYTOLOGY; FEMALE; HUMAN; LUNG; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SMALL CELL CARCINOMA; STANDARD;

AGED; AGED, 80 AND OVER; BIOPSY; BRONCHI; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CELL BIOLOGY; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY OF RESULTS;

EID: 77958573947     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Yang P, Allen MS, Aubry MC, et al. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest. 2005; 128(1):452-462.
2. Scott WJ, Howington J, Feigenberg S, et al. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3)(suppl):234S-242S. (Pubitemid 47502810)
3. Robinson LA, Ruckdeschel JC, Wagner H Jr, et al. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3)(suppl):243S-265S.
4. Jett JR, Schild SE, Keith RL, Jett JR, Schild SE, Keith RL, Kesler KA; American College of Chest Physicians. Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132(3)(suppl):266S-276S.
5. Socinski MA, Crowell R, Hensing TE, et al. Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3)(suppl):277S-289S. (Pubitemid 47502813)
6. Simon GR, Turrisi A; American College of Chest Physicians. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3)(suppl):324S-339S.
7. Rivera MP, Mehta AC; American College of Chest Physicians. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3)(suppl):131S-148S.
8. Cataluna JJ, Perpina M, Greses JV, Calvo V, Padilla JD, Paris F. Cell type accuracy of bronchial biopsy specimens in primary lung cancer. Chest. 1996; 109(5):1199-1203.
9. Matsuda M, Horai T, Nakamura S, et al. Bronchial brushing and bronchial biopsy: comparison of diagnostic accuracy and cell typing reliability in lung cancer. Thorax. 1986;41(6):475-478.
10. Rudd RM, Gellert AR, Boldy DA, et al. Bronchoscopic and percutaneous aspiration biopsy in the diagnosis of bronchial carcinoma cell type. Thorax. 1982;37(6):462-465.
11. Clee MD, Duguid HL, Sinclair DJ. Accuracy of morphological diagnosis of lung cancer in a department of respiratory medicine. J Clin Pathol. 1982;35(4): 414-419.
12. Payne CR, Hadfield JW, Stovin PG, Barker V, Heard BE, Stark JE. Diagnostic accuracy of cytology and biopsy in primary bronchial carcinoma. J Clin Pathol. 1981;34(7):773-778.
13. Committee on Quality of Healthy Care in America, Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press; 2001:337.
14. Raab SS, Nakhleh RE, Ruby SG. Patient safety in anatomic pathology: measuring discrepancy frequencies and causes. Arch Pathol Lab Med. 2005; 129(4):459-466.
15. Kohn LT, Corrigan JM, Donaldson MS, editors. To err is human: building a safer health system. Washington, DC: National Academy Press; 2000:287.
16. Raab SS, Stone CH, Wojcik EM, et al. Use of a new method in reaching consensus on the cause of cytologic-histologic correlation discrepancy. Am J Clin Pathol. 2006;126(6):836-842.
17. Saha R, Thapa M. Correlation of cervical cytology with cervical histology. Kathmandu Univ Med J (KUMJ). 2005;3(3):222-224.
18. Pradhan B, Pradhan SB, Mital VP. Correlation of Pap smear findings with clinical findings and cervical biopsy. Kathmandu Univ Med J (KUMJ). 2007;5(4): 461-467.
19. Jones BA, Novis DA. Cervical biopsy-cytology correlation: a College of American Pathologists Q-Probes study of 22,439 correlations in 348 laboratories. Arch Pathol Lab Med. 1996;120(6):523-531.
20. Clary KM, Silverman JF, Liu Y, et al. Cytohistologic discrepancies: a means to improve pathology practice and patient outcomes. Am J Clin Pathol. 2002; 117(4):567-573.
21. Renshaw AA. Measuring and reporting errors in surgical pathology: lessons from gynecologic cytology. Am J Clin Pathol. 2001;115(3):338-341.
22. Ogino S, Franks TJ, Yong M, Koss MN. Extensive squamous metaplasia with cytologic atypia in diffuse alveolar damage mimicking squamous cell carcinoma: a report of 2 cases. Hum Pathol. 2002;33(10):1052-1054.
23. Crapanzano JP, Zakowski MF. Diagnostic dilemmas in pulmonary cytology. Cancer. 2001;93(6):364-375.
24. DeMay RM. The Art and Science of Cytopathology. Chicago, IL: ASCP Press; 1996.
25. Naryshkin S, Young NA. Respiratory cytology: a review of non-neoplastic mimics of malignancy. Diagn Cytopathol. 1993;9(1):89-97.
26. Wu M, Wang B, Gil J, et al. p63 and TTF-1 immunostaining: a useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol. 2003;119(5): 696-702.
27. Lyda MH, Weiss LM. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas. Hum Pathol. 2000;31(8):980-987.
28. Marchevsky AM, Gal AA, Shah S, Koss MN. Morphometry confirms the presence of considerable nuclear size overlap between "small cells" and "large cells" in high-grade pulmonary neuroendocrine neoplasms. Am J Clin Pathol. 2001;116(4):466-472.
29. Travis WD, Gal AA, Colby TV, Klimstra DS, Falk R, Koss MN. Reproducibility of neuroendocrine lung tumor classification. Hum Pathol. 1998;29(3):272-279.
30. Raab SS, Oweity T, Hughes JH, et al. Effect of clinical history on diagnostic accuracy in the cytologic interpretation of bronchial brush specimens. Am J Clin Pathol. 2000;114(1):78-83.
31. Tsung JS. Institutional pathology consultation. Am J Surg Pathol. 2004; 28(3):399-402.
32. Pilotti S, Rilke F, Gribaudi G, Spinelli P. Cytologic diagnosis of pulmonary carcinoma on bronchoscopic brushing material. Acta Cytol. 1982;26(5):655-660.
33. Sandler A. Bevacizumab in non small cell lung cancer. Clin Cancer Res. 2007;13(15, pt 2):s4613-s4616.
34. Cabebe E, Wakelee H. Role of anti-angiogenesis agents in treating NSCLC: focus on bevacizumab and VEGFR tyrosine kinase inhibitors. Curr Treat Options Oncol. 2007;8(1):15-27.